Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov:85:104502.
doi: 10.1016/j.meegid.2020.104502. Epub 2020 Aug 13.

From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses

Nikhil Kirtipal  1 , Shiv Bharadwaj  2 , Sang Gu Kang  3
Affiliations
Review

From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses

Nikhil Kirtipal et al. Infect Genet Evol. 2020 Nov.

Abstract

Human Coronaviruses (HCoV), periodically emerging across the world, are potential threat to humans such as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) - diseases termed as COVID-19. Current SARS-CoV-2 outbreak have fueled ongoing efforts to exploit various viral target proteins for therapy, but strategies aimed at blocking the viral proteins as in drug and vaccine development have largely failed. In fact, evidence has now shown that coronaviruses undergoes rapid recombination to generate new strains of altered virulence; additionally, escaped the host antiviral defense system and target humoral immune system which further results in severe deterioration of the body such as by cytokine storm. This demands the understanding of phenotypic and genotypic classification, and pathogenesis of SARS-CoV-2 for the production of potential therapy. In lack of clear clinical evidences for the pathogenesis of COVID-19, comparative analysis of previous pandemic HCoVs associated immunological responses can provide insights into COVID-19 pathogenesis. In this review, we summarize the possible origin and transmission mode of CoVs and the current understanding on the viral genome integrity of known pandemic virus against SARS-CoV-2. We also consider the host immune response and viral evasion based on available clinical evidences which would be helpful to remodel COVID-19 pathogenesis; and hence, development of therapeutics against broad spectrum of coronaviruses.

Keywords: Angiotensin-converting enzyme 2; COVID-19; Cytokine storm; Human coronaviruses; Interferons; Interleukin.

PubMed Disclaimer

Conflict of interest statement

Authors declares no conflict of interest.

Figures

Unlabelled Image
Graphical abstract
Fig. 1
Fig. 1
The taxonomic (a) classification and positions for the known seven HCoVs, and (b) phylogenetic tree analysis of CoVs constructed based on S gene using Molecular Evolutionary Genetics Analysis 6 software under neighbor-joining method and 1000 bootstrap values (Biswas et al., 2020).
Fig 2
Fig 2
Schematic representation of three HCoVs, viz. SARS-CoV, MERS-CoV, and SARS-CoV-2, transmission to human from bat through intermediate hosts.
Fig. 3
Fig. 3
A typical structure of CoV (80-120 nm) exhibiting various structural proteins, i.e. S, M, E, and genomic RNA packed inside the particle by N protein.
Fig. 4
Fig. 4
Schematic representation for (a) genome organization and (b) functional domains in the genome of SARS-CoV, MERS-CoV, and SARS-CoV-2.
Fig. 5
Fig. 5
Schematic representation for HCoVs attachment and entry into airway cells. The envelope spike glycoprotein binds to its cellular receptor ACE2 for SARS-CoV and DPP4 for MERS-CoV.
Fig. 6
Fig. 6
An overview for the life cycle of HCoVs in the host-cell (Song et al., 2019; Zumla et al., 2015)
Fig. 7
Fig. 7
Cytokine pathogenesis of coronavirus disease (Yi et al., 2020).
Fig. 8
Fig. 8
Possible mechanisms of SARS-CoV-2-mediated inflammatory responses based on previous study of SARS-CoV (Fu et al., 2020).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ar Gouilh M., Puechmaille S.J., Diancourt L., Vandenbogaert M., Serra-Cobo J., Lopez Roig M., Brown P., Moutou F., Caro V., Vabret A., Manuguerra J.C. SARS-CoV related Betacoronavirus and diverse Alphacoronavirus members found in western old-world. Virology. 2018;517:88–97. - PMC - PubMed
    1. Arbour N., Ekande S., Cote G., Lachance C., Chagnon F., Tardieu M., Cashman N.R., Talbot P.J. Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E. J. Virol. 1999;73:3326–3337. - PMC - PubMed
    1. Arbour N., Day R., Newcombe J., Talbot P.J. Neuroinvasion by human respiratory coronaviruses. J. Virol. 2000;74:8913–8921. - PMC - PubMed
    1. Ashour H.M., Elkhatib W.F., Rahman M.M., Elshabrawy H.A. Insights into the Recent 2019 novel coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks. Pathogens. 2020;9 - PMC - PubMed
    1. Barcena M., Oostergetel G.T., Bartelink W., Faas F.G.A., Verkleij A., Rottier P.J.M., Koster A.J., Bosch B.J. Cryo-electron tomography of mouse hepatitis virus: Insights into the structure of the coronavirion. Proc. Nat. Acad. Sci. U. S. A. 2009;106:582–587. - PMC - PubMed

MeSH terms